DURECT Corporation DRRX Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

May 18, 2022 (filed on May 18, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

29,911

Price:

$0.41
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,800

Price:

$0.42
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

8,900

Price:

$0.42
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,300

Price:

$0.42
May 16, 2022 (filed on May 18, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

25,300

Price:

$0.39
May 16, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$0.38
May 13, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,250

Price:

$0.40
May 12, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,500

Price:

$0.39
May 11, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,950

Price:

$0.40
May 10, 2022 (filed on May 12, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

2,339

Price:

$0.41

Filings by filing date

May 18, 2022 (filed on May 18, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

29,911

Price:

$0.41
May 16, 2022 (filed on May 18, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

25,300

Price:

$0.39
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,800

Price:

$0.42
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

8,900

Price:

$0.42
May 17, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,300

Price:

$0.42
May 16, 2022 (filed on May 18, 2022)

Insider Name:

Azab Mohammad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$0.38
May 13, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,250

Price:

$0.40
May 12, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,500

Price:

$0.39
May 11, 2022 (filed on May 13, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

9,950

Price:

$0.40
May 10, 2022 (filed on May 12, 2022)

Insider Name:

Farfel Gail M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

2,339

Price:

$0.41

Company Contact

Address:	10260 Bubb Rd CUPERTINO CA 95014-4166
Tel:	1-646-3782928
Website:	www.durect.com
IR:	See website

Key People

James E. Brown President, Chief Executive Officer, Director	Judy R. Joice Senior Vice President - Operations and Corporate Quality Assurance	Jian Li Interim Principal Accounting Officer
Norman L. Sussman Chief Medical Officer

Employees:	78 as of Mar 31, 2022

Reporting Currency:	U.S. Dollars
Enterprise value:	$46.90M as of Mar 31, 2022
Annual revenue (TTM):	$13.68M as of Mar 31, 2022
EBITDA (TTM):	-$34.86M as of Mar 31, 2022
Net annual income (TTM):	-$36.97M as of Mar 31, 2022
Free cash flow (TTM):	-$32.39M as of Mar 31, 2022
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	227,764,019 as of May 3, 2022
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

DURECT Corporation (OQ:DRRX)

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Filings by filing date

News

Biz Brief

INK Ultra Money Free

Sector: Healthcare	Industry: Biotechnology & Medical Research

See Regulatory Filings on SEC